Eighty percent of doctors in a Medscape survey answered no when asked, “Is enough known about obesity meds’ risk to ...

A clinical practice guideline from the American College of Physicians. Ann Intern Med 2005 Apr 5; 142:525-31. Li Z et al. Meta-analysis: Pharmacologic treatment of obesity. Ann Intern Med 2005 Apr ...

Alcoholic beverages should carry a more specific label warning about cancer risks, the U.S. surgeon general said on Fri ...

Recent research reveals five distinct subtypes of diabetes, offering a nuanced understanding of this chronic condition. This ...

A link between consuming alcohol and cancer risk has been determined for at least seven types of cancer, namely breast, colorectum, esophagus, liver, mouth (oral cavity), throat (pharynx) and voice ...

The U.S. Surgeon General issued an advisory Friday recommending updated warning labels on alcoholic beverages.

Any established drug being applied to obesity (e.g. the application of ... should be included as supplementary material. Detailed guidelines for submitting artwork can be found by downloading ...

Orlistat has FDA approval for the treatment of obesity management ... Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions ...

Guidelines recommend ≥30 min of physical activity ... both semaglutide and tirzepatide had received Food and Drug Administration (FDA) approval for treatment of obesity. The CV benefits of GLP1RAs ...

The number of people with chronic pain has increased substantially in recent years, and the reason isn’t completely clear. A report, issued by the Centers for Disease Control and Prevention and the ...

The WHO is currently in the process of drafting guidelines for the use of GLP-1 receptor agonists in adults with obesity to provide clarity on ... marking the first chronic weight management treatment ...